With TCT in full swing, Or Yehuda, Israel-based Cardiovalve is launching the AHEAD US Multicenter Study, and jumping head first into the quickly growing TMVR market.
The Menlo Park, CA-based company said it has raised $10 million in a series B to help support a clinical study of its technology.
The company’s Phoenix device is a bioelectric medicine that has the potential to treat functional diseases such as type-2 diabetes, hypertension, and gastroesophageal reflux disease.
Seven key trends and events helped make Liquid Biopsy attractive to investors, shareholders, patients, and physicians.
Financings, joint ventures, and clearances continue to drive the quickly growing surgical robotics market.
LivaNova is launching a pivotal study that will look at how stimulation of the vagus nerve with the VITARIA device can help treat heart failure patients.
The Los Alamitos, CA-based company has received FDA clearance for the Infrared Heat Therapy Pain Relief wearable.
Audrey Turley, of Nelson Labs, will speak at Medical Design & Manufacturing Minneapolis about biocompatibility issues related to medical devices including the move to more in vitro testing and the 2020 deadline for the new European Medical Device Regulation.
The Cupertino, CA-based company garnered a lot of attention for incorporating an ECG into the next iteration of the Apple Watch and now analysts along with industry experts are sounding off on the technology’s potential impact.
In July, AngioDynamics’ CEO promised the company would be turning toward M&A to enhance growth opportunities.
The Redwood City, CA based company said that private information from about 1,100 individuals was exposed due to the cybersecurity attack.